Edition:
United States

SINOPHARM GROUP CO LTD (1099.HK)

1099.HK on Hong Kong Stock

32.70HKD
15 Feb 2018
Change (% chg)

HK$-0.20 (-0.61%)
Prev Close
HK$32.90
Open
HK$32.95
Day's High
HK$33.10
Day's Low
HK$32.55
Volume
2,479,413
Avg. Vol
5,778,123
52-wk High
HK$37.85
52-wk Low
HK$29.85

Chart for

About

Sinopharm Group Company Limited is principally engaged in the distribution of pharmaceutical products and medical equipment. The Company operates through three business segments. The Pharmaceutical Distribution segment is engaged in the distribution of medicines, medicine devices and pharmaceutical products to hospitals, other... (more)

Overall

Beta: 0.90
Market Cap(Mil.): HK$90,484.01
Shares Outstanding(Mil.): 2,767.09
Dividend: 0.57
Yield (%): 1.75

Financials

  Industry Sector
P/E (TTM): -- 20.16 17.27
EPS (TTM): -- -- --
ROI: -- 11.61 35.43
ROE: -- 13.76 17.10

BRIEF-Sinopharm Group Co's Board Resolves To Propose Issue Of Corporate Bonds In China

* BOARD RESOLVED TO PROPOSE ISSUE OF CORPORATE BONDS IN PRC; ISSUE SIZE OF NO MORE THAN RMB10 BILLION Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

Jan 12 2018

BRIEF-Sinopharm Group posts ‍9-mnth profit attributable of RMB ‍3.66​ billion​

* 9-month net profit attributable to equity holders of co RMB ‍3.66​ billion versus RMB3.60 billion

Oct 29 2017

BRIEF-Sinopharm Group clarifies on research report published by a financial research company

* Aware of research report published by a financial research company questioning co's accounting recognition of operating cash flow

Sep 27 2017

BRIEF-China Ludao Technology Co announces formation of JV

* Ludao PRC, Sinopharm TCM and Lu Xian Cao Tang entered into capital contribution agreement

Sep 11 2017

BRIEF-Sinopharm Group Co Ltd posts HY profit attributable rmb2.76 billion

* HY profit attributable to owners of parent RMB2.76 billion versus RMB2.53 billion

Aug 27 2017

Earnings vs. Estimates